CANCER 2026 , ,
Presentations this author is a contributor to:
Rewiring Hormone Therapy: Efficacy and Tolerability of High-Dose Testosterone in Advanced Prostate Cancer (131880)
12:45 PM
Mitchell Lawrence
Session 7: The tumour microenvironment and metastasis
Expanding the utility of PARP inhibitors using combination therapy with androgen receptor signalling inhibitors in prostate cancer (#245)
5:35 PM
Mahsa Rostamiandelavar
Poster Session 2